Literature DB >> 23983992

Neuroleptic malignant syndrome associated with quetiapine and venlafaxine use: a case report and discussion.

Gary Woods1, Catherine Taggart, Robert Boggs, Ian Cadden.   

Abstract

Entities:  

Year:  2013        PMID: 23983992      PMCID: PMC3736958          DOI: 10.1177/2045125312464386

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN: 2045-1253


× No keyword cloud information.
  10 in total

Review 1.  The serotonin syndrome.

Authors:  H Sternbach
Journal:  Am J Psychiatry       Date:  1991-06       Impact factor: 18.112

2.  Neuroleptic malignant syndrome after exposure to asenapine: a case report.

Authors:  Niku Singh; Thomas N Wise
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

3.  A rating scale for neuroleptic malignant syndrome.

Authors:  Perminder S Sachdev
Journal:  Psychiatry Res       Date:  2005-06-30       Impact factor: 3.222

4.  Comparison of neuroleptic malignant syndrome induced by first- and second-generation antipsychotics.

Authors:  Julian N Trollor; Xiaohua Chen; Kate Chitty; Perminder S Sachdev
Journal:  Br J Psychiatry       Date:  2012-05-24       Impact factor: 9.319

Review 5.  Clinical management of neuroleptic malignant syndrome.

Authors:  V L Susman
Journal:  Psychiatr Q       Date:  2001

6.  Neuroleptic malignant syndrome after the use of venlafaxine in a patient with generalized anxiety disorder.

Authors:  Tsung-Chien Lu; Pei-Lun Chu; Chi-Shin Wu; Kuang-Chau Tsai; Wen-Jone Chen
Journal:  J Formos Med Assoc       Date:  2006-01       Impact factor: 3.282

7.  Quetiapine and citalopram: aetiological significances in serotonin syndrome.

Authors:  Karl Marlowe; Dorothea Schirgel
Journal:  N Z Med J       Date:  2006-07-07

Review 8.  Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics?

Authors:  Yuji Odagaki
Journal:  Curr Drug Saf       Date:  2009-01

Review 9.  Association between selective serotonin-reuptake inhibitors, second-generation antipsychotics, and neuroleptic malignant syndrome.

Authors:  Debra L Stevens
Journal:  Ann Pharmacother       Date:  2008-07-15       Impact factor: 3.154

10.  Risk factors in neuroleptic malignant syndrome. A case-control study.

Authors:  L F Viejo; V Morales; P Puñal; J L Pérez; R A Sancho
Journal:  Acta Psychiatr Scand       Date:  2003-01       Impact factor: 6.392

  10 in total
  2 in total

1.  The role of electroencephalography in the diagnosis of serotonin syndrome.

Authors:  Theeba Krishnamoorthy; John Knighton; Louis Merton
Journal:  J Intensive Care Soc       Date:  2016-02-10

2.  Forced Diuresis and Expedient Blood Pressure Control in the Management of Quetiapine Induced Neuroleptic Malignant Syndrome: A Case Report.

Authors:  Neville Aquilina; Vincent Bugeja
Journal:  Open Access Maced J Med Sci       Date:  2018-06-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.